Genetic Polymorphisms and Breast Cancer Risk

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 7, 1997, Pages 533-

  Kazandjian, Vahe A ^a  

^a Hospitals and Health Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BENZIDINE; ARYLAMINE ACETYLTRANSFERASE;

BLADDER CANCER; BREAST CANCER; CANCER GENETICS; CANCER RISK; CHEMICAL CARCINOGENESIS; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LETTER; ONCOGENE; PRIORITY JOURNAL; BREAST TUMOR; CHEMICAL INDUSTRY; ENZYMOLOGY; GENETICS; METABOLISM; NOTE; OCCUPATIONAL EXPOSURE; RISK FACTOR;

ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CHEMICAL INDUSTRY; HUMANS; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0031043906     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540310031027     Document Type: Letter

References (3)

1. Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA. 1996;276:1494-1501.
2. Correction: JAMA. 1997;277:534.
3. Logan RL, Scott PJ. Uncertainty in clinical practice: implications for quality and costs of health care. Lancet. 1996;347:595-598.